A Novel, IBS-Specific IgG ELISA-Based Elimination Diet in Irritable Bowel Syndrome: A Randomized, Sham-Controlled TrialPrashant Singh, Anthony Lembo, William D. Chey et al.|Gastroenterology|2025Cited by 27
A Phase 2b, Randomised, Double-blind, Placebo-controlled, Parallel-arm, Multicenter Study Evaluating the Safety and Efficacy of Tesnatilimab in Patients with Moderately to Severely Active Crohn’s DiseaseMatthieu Allez, Taku Kobayashi, Gert De Hertogh et al.|Journal of Crohn s and Colitis|2023Cited by 11